| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Oliver D Howes, Niko Seppälä, Christoph U Correl. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 84. 2024-04-24. PMID:38657339. |
in this narrative review and expert opinion, we summarized information available in the literature on the mechanisms of action, effectiveness, and potential adverse events of clozapine. |
2024-04-24 |
2024-04-28 |
Not clear |
| Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Oliver D Howes, Niko Seppälä, Christoph U Correl. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 84. 2024-04-24. PMID:38657339. |
overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: a narrative review and recommendation for clinical practice. |
2024-04-24 |
2024-04-28 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
the evidence of clozapine dosage affecting eosinophil and c-reactive protein levels in this patient was summarized in a table and a narrative review. |
2023-09-05 |
2023-09-07 |
Not clear |
| Stefan J Berger, Alex Hofe. [Safety aspects during treatment with clozapine: : Adverse effects, titration, and therapeutic drug monitoring - a narrative review]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. 2023-06-22. PMID:37349671. |
the first part of this narrative overview focuses on the most frequent side effects of clozapine, on the relevance of slow titration, and on specific aspects of therapeutic drug monitoring (tdm). |
2023-06-22 |
2023-08-14 |
Not clear |
| Stefan J Berger, Alex Hofe. [Safety aspects during treatment with clozapine: : Adverse effects, titration, and therapeutic drug monitoring - a narrative review]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. 2023-06-22. PMID:37349671. |
[safety aspects during treatment with clozapine: : adverse effects, titration, and therapeutic drug monitoring - a narrative review]. |
2023-06-22 |
2023-08-14 |
Not clear |
| Mishal Qubad, Robert A Bittne. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic advances in psychopharmacology. vol 13. 2023-03-30. PMID:36994117. |
this narrative review summarizes all clinically relevant areas of evidence, which support clozapine's wide-ranging superior efficacy - for treatment-resistant schizophrenia (trs) and beyond - and make its safe use eminently feasible. |
2023-03-30 |
2023-08-14 |
Not clear |
| Diana Rey Souto, Justo Pinzón Espinosa, Eduard Vieta, Antoni Benabarre Hernánde. Clozapine in patients with schizoaffective disorder: A systematic review. Revista de psiquiatria y salud mental. vol 14. issue 3. 2021-10-28. PMID:34400122. |
the evidence was summarized both in a table and a narrative fashion, suggesting that clozapine may be an effective treatment for both psychotic and affective symptoms, indistinctively of an acute or maintenance phase. |
2021-10-28 |
2023-08-13 |
Not clear |
| Dara Gammon, Catherine Cheng, Anna Volkovinskaia, Glen B Baker, Serdar M Dursu. Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders? Biomolecules. vol 11. issue 7. 2021-10-06. PMID:34356654. |
a literature review on the applications of clozapine and electroconvulsive therapy (ect) to the disorders mentioned above was undertaken, and this narrative review was prepared. |
2021-10-06 |
2023-08-13 |
Not clear |
| H Verdoux, C Quile. Educational needs and psychoeducation interventions in clozapine users: a narrative review. Acta psychiatrica Scandinavica. vol 142. issue 2. 2021-07-12. PMID:32266962. |
educational needs and psychoeducation interventions in clozapine users: a narrative review. |
2021-07-12 |
2023-08-13 |
Not clear |
| Jose de Leon, Georgios Schoretsanitis, John M Kane, Can-Jun Rua. Using therapeutic drug monitoring to personalize clozapine dosing in Asians. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists. vol 12. issue 2. 2021-03-24. PMID:32119764. |
this narrative review on clozapine blood levels or therapeutic drug monitoring (tdm) includes sections focused on drug clearance and tdm, personalized dosing with tdm, clinical applications of tdm in asians, and areas needing further study. |
2021-03-24 |
2023-08-13 |
Not clear |
| Hélène Verdoux, Clélia Quiles, Jose de Leo. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review. Schizophrenia research. vol 211. 2020-09-22. PMID:31378552. |
clinical determinants of fever in clozapine users and implications for treatment management: a narrative review. |
2020-09-22 |
2023-08-13 |
Not clear |
| Kenya A Costa-Dookhan, Sri Mahavir Agarwal, Araba Chintoh, Veronica N Tran, Nicolette Stogios, Bjørn H Ebdrup, Sanjeev Sockalingam, Tarek K Rajji, Gary J Remington, Dan Siskind, Margaret K Hah. The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy. Expert opinion on drug safety. vol 19. issue 1. 2020-01-09. PMID:31770500. |
the clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy. |
2020-01-09 |
2023-08-13 |
Not clear |
| Shiva Shanker Reddy Mukku, P T Sivakumar, Mathew Varghes. Clozapine use in geriatric patients- Challenges. Asian journal of psychiatry. vol 33. 2018-10-01. PMID:29529421. |
in this narrative review, we discuss clozapine use in elderly and challenges associated with its use. |
2018-10-01 |
2023-08-13 |
Not clear |